1448316-75-3

Upstream product

• 1448316-74-2 N-{2,4-dimethyl-5-[6-(pyridin-3-yl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl}-3-(2-hydroxypropan-2-yl)benzamide 
• 585-76-2 m-bromobenzoic acid 
• 1448317-38-1 1-(2,4-dimethyl-5-nitrophenyl)-6-(pyridin-3-yl)-1H-imidazo[1,2-b]pyrazole 
• 1448317-37-0 1-(2,2-diethoxyethyl)-N-(2,4-dimethyl-5-nitrophenyl)-3-(pyridin-3-yl)-1H-pyrazole-5-amine 
• 222056-48-6 1-(2,2-diethoxyethyl)-3-(pyridin-3-yl)-1H-pyrazole-5-amine 
• 30510-18-0 nicotinoylacetonitrile 

Relevant academic research and scientific papers

Substituted phenylimidazopyrazoles and their use

The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.